CLINICAL_TRIALS
trial_result
· 2025-12-16
Clinical Trial Update: Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens [Phase 4]
Summary
Phase 4 trial results update assessing efficacy and safety of rimegepant for the prevention of episodic migraine across multiple dosing regimens.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2025-12-16